Company profile: CosmosID
1.1 - Company Overview
Company description
- Provider of metagenomics and bioinformatics services for rapid identification of microorganisms in various samples, offering strain-level analysis via proprietary pipeline and database to detect bacteria, viruses, fungi, and more. Provides sequencing services (amplicon, shallow/deep shotgun, bacterial isolate) and CosmosID-HUB Microbiome, an online platform with pipelines for amplicon and shotgun data, plus targeted tests and whole genome analysis.
Products and services
- Bioinformatics Services: CosmosID delivers strain-level metagenomics analysis using a proprietary pipeline and database, identifying bacteria, viruses, fungi, and other microorganisms
- CosmosID-HUB Microbiome: Online platform enabling fast, accessible analysis of complex metagenomic data, supplying pipelines for amplicon and shotgun data analysis
- Metagenomics Analysis Services: CosmosID supplies NGS-based analysis of microbial communities in various samples, including targeted tests and whole genome analysis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CosmosID
Baseclick
HQ: Germany
Website
- Description: Provider of click chemistry reagents (clickable dyes, tags, sugars, amino acids), custom DNA/RNA/LNA oligonucleotide synthesis, mRNA synthesis and modification, EdU cell proliferation assays, FISH and PCR kits, and click chemistry-based NGS solutions for full-length transcriptomics compatible with all sequencing devices; also offers licensing of proprietary click chemistry and DNA photography technologies and collaboration for further development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baseclick company profile →
Yourgene Health
HQ: United Kingdom
Website
- Description: Provider of molecular diagnostics employing next generation DNA analysis technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Yourgene Health company profile →
Caribou Biosciences
HQ: United States
Website
- Description: Provider of CRISPR genome-editing technologies and allogeneic CAR-T cell therapies for oncology. Offers chRDNA to enhance precision and reduce off-target effects; off-the-shelf CAR-T therapies for hematologic malignancies and autoimmune diseases; and candidates CB-010 (anti-CD19 for B cell non-Hodgkin lymphoma), CB-011 (anti-BCMA for multiple myeloma), and CB-012 (anti-CLL-1 for acute myeloid leukemia).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caribou Biosciences company profile →
OXGENE
HQ: United Kingdom
Website
- Description: Provider of versatile cloning plasmids for research, custom cloning and DNA synthesis, and IP-free products. Offers TESSA technology for scalable, cost-effective AAV manufacturing, high-titre transient rAAV production, cell and gene therapy acceleration services (including CAR-T), cell line development and engineering, and LentiVEX plasmids and cell lines for lentiviral vector production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OXGENE company profile →
MIDI
HQ: United States
Website
- Description: Provider of chemical analysis and microbial identification solutions for agriculture and environmental microbiology laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MIDI company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CosmosID
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CosmosID
2.2 - Growth funds investing in similar companies to CosmosID
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CosmosID
4.2 - Public trading comparable groups for CosmosID
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →